NN Investment Partners Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.35M | Sell |
14,377
-6,460
| -31% | -$606K | 0.01% | 598 |
|
|
2021
Q4 | $1.77M | Buy |
20,837
+1,102
| +6% | +$93.8K | 0.01% | 562 |
|
|
2021
Q3 | $1.89M | Sell |
19,735
-11,481
| -37% | -$1.1M | 0.01% | 559 |
|
|
2021
Q2 | $3.04M | Sell |
31,216
-66,546
| -68% | -$6.48M | 0.02% | 497 |
|
|
2021
Q1 | $9.51M | Sell |
97,762
-2,719
| -3% | -$264K | 0.06% | 282 |
|
|
2020
Q4 | $9.63M | Buy |
100,481
+88,945
| +771% | +$8.53M | 0.06% | 256 |
|
|
2020
Q3 | $1.11M | Hold |
11,536
| – | – | 0.01% | 581 |
|
|
2020
Q2 | $1.41M | Buy |
11,536
+3,648
| +46% | +$445K | 0.01% | 561 |
|
|
2020
Q1 | $682K | Sell |
7,888
-2,700
| -26% | -$233K | 0.01% | 615 |
|
|
2019
Q4 | $1.14M | Buy |
+10,588
| New | +$1.14M | 0.01% | 591 |
|
|
2018
Q3 | – | Sell |
-2,651
| Closed | -$260K | – | 672 |
|
|
2018
Q2 | $260K | Sell |
2,651
-1,128
| -30% | -$111K | ﹤0.01% | 600 |
|
|
2018
Q1 | $313K | Sell |
3,779
-297,321
| -99% | -$24.6M | ﹤0.01% | 604 |
|
|
2017
Q4 | $23.4M | Buy |
301,100
+32,158
| +12% | +$2.5M | 0.17% | 129 |
|
|
2017
Q3 | $16.5M | Buy |
268,942
+60,780
| +29% | +$3.72M | 0.1% | 173 |
|
|
2017
Q2 | $9.58M | Buy |
+208,162
| New | +$9.58M | 0.09% | 178 |
|